Clinical Trial

Effect of a Cepham Supplement on Hot Flashes and Menopausal Symptoms in Postmenopausal Women

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 23, 2025 (before its estimated August 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
The goal of this clinical trial is to learn if a daily nutritional supplement can reduce hot flashes and other menopausal symptoms in postmenopausal women. The main questions this study aims to answer are: Does the supplement reduce the number and severity of daily hot flashes? Does it improve other common menopausal symptoms? Researchers will compare the supplement to a placebo (a look-alike capsule with no active ingredients) to see if it helps manage symptoms during menopause. Participants will: Take either the supplement or a placebo daily for 30 days Track their hot flashes each day using a short online survey Complete a symptom questionnaire at the beginning and end of the study This study is for women ages 40-60 who have been postmenopausal for at least one year and currently experience bothersome hot flashes.
Trial Details
NCT Number NCT06939868
Lead Sponsor Jacksonville University
Conditions D008593
Enrollment 44 participants
Start Date 2025-05-01
Primary Completion 2025-08-30 (estimated)
Study Completion 2025-09-30 (estimated)
Updated on ClinicalTrials.gov 2025-04-23